The Real‐World Effect of 12 Months of Romosozumab Treatment on Patients With Osteoporosis With a High Risk of Fracture and Factors Predicting the Rate of Bone Mass Increase: A Multicenter Retrospective Study

Excluding clinical trials, there is limited evidence on the effect of 12 months of romosozumab treatment on bone mineral density (BMD) increase in real‐world clinical practice because its use has only been approved recently. Thus, this study aimed to investigate the real‐world effect of 12 months of...

Descripción completa

Detalles Bibliográficos
Autores principales: Inose, Hiroyuki, Ariga, Akane, Motoyoshi, Takayuki, Fukushima, Kazuyuki, Tomizawa, Shoji, Kato, Tsuyoshi, Takahashi, Kunihiko, Yoshii, Toshitaka, Okawa, Atsushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289984/
https://www.ncbi.nlm.nih.gov/pubmed/35866147
http://dx.doi.org/10.1002/jbm4.10637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289984/
https://www.ncbi.nlm.nih.gov/pubmed/35866147
http://dx.doi.org/10.1002/jbm4.10637

Ejemplares similares